Poster

Advancing mast cell research with a standardized human primary cell platform

Chenyan Wu1, Cyprien Pecalvel1, Anthony David1 and Nicolas Gaudenzio1,2
1Genoskin SAS, 2INSERM UMR1291 – CNRS UMR5051, University Toulouse III

Understanding mast cell activation in a human-relevant context

Mast cells play a central role in immune regulation, inflammation and allergic responses, making them highly relevant for immunology and safety research. Understanding their activation and mediator release is essential to characterize inflammatory pathways and evaluate the biological effects of new compounds, formulations, and therapeutic candidates.

Genoskin’s human primary mast cells are derived from peripheral blood CD34+ progenitors and differentiated into mature, functional mast cells. Each donor batch undergoes standardized phenotypic and functional quality control to ensure consistent characterization and responsiveness.

The poster demonstrates robust mast cell activation through IgE-dependent and non-IgE-dependent pathways, with degranulation responses to clinically relevant compounds, including PACAP38 and cetrorelix. It also highlights preserved cell viability and functionality after shipment, as well as the complementary use of HypoSkin® for tissue-level investigations.

Genoskin’s standardized human primary mast cell platform supports immunology research, drug safety assessment, and the evaluation of mast cell-targeting therapeutics, providing human-relevant data to inform preclinical development.

Please fill in the form below to access the full poster.

After submitting this form, you will receive an email with the link to access our poster.

Need help choosing the right model for your research?

Want more research like this in your inbox? Subscribe to our newsletter →

Comments are closed.